Voters in Detroit Pass Initiative to Decriminalize Psychedelic Substances

Voters in the city of Detroit have passed a ballot measure that will decriminalize psychedelic substances. Detroit is the latest city to enact the reform in the country. Unofficial results released last week showed that the initiative led by a 61% margin, with all precincts reporting their data.

The measure stipulates that the city will decriminalize the therapeutic use and personal possession of entheogenic plants by individuals aged 18 and above, as permitted under the law in the state of Michigan. This is in addition to making the therapeutic use and personal possession of entheogenic plants the lowest law-enforcement priority in the city.

In the last few months, the state of Michigan has become a hot spot for psychedelic reform, with the city council of Ann Arbor recently making the enforcement of laws prohibiting the use of psychedelic substances, such as DMT, ayahuasca and psilocybin, the lowest priorities for law enforcement in the city. Legislators in the city also made September the Entheogenic Fungi and Plants Awareness month. The city council of Grand Rapids also approved a measure to decriminalize various psychedelic substances in September.

Advocates for psychedelics reform in other parts of the country are also calling for reform, with legislators in the city of Easthampton voting on a measure to decriminalize entheogenic substances and other drugs.

This comes a few months after the city council of Northampton approved a measure stipulating that no police or government funds should be utilized in the enforcement of laws that criminalize individuals for being in possession of or using entheogenic fungi and plants.

Cambridge and Somerville, also in the state of Massachusetts, have enacted reforms to decriminalize psychedelic substances. Additionally, the city council of Seattle passed an initiative in October that would decriminalize non-commercial activity around an extensive range of psychedelics, including the growing and sharing of non–peyote-derived mescaline, ibogaine, ayahuasca and psilocybin mushrooms.

In California, a measure to legalize psychedelic substances that had advanced through two Assembly committees and the Senate was pulled by Sen. Scott Wiener. Wiener, who is the measure’s sponsor, explained that this would give the measure more time to generate support among legislators. Activists in the state have also started to gather signatures for a measure to legalize hallucinogenic mushrooms in the state, having received clearance to proceed.

Last year, voters in the state of Oregon approved two measures that would decriminalize the possession of all drugs and legalize psilocybin therapy.

Given how much progress companies such as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) are making it their quest to develop novel treatments derived from psychedelic compounds, the exploding movement calling for psychedelic policy reform becomes understandable.

NOTE TO INVESTORS: The latest news and updates relating to Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.


Select A Month

PsychedelicNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 415.949.5050